Article
Pharmacogenetic testing for guiding de novo phenprocoumon therapy in stroke patients.
Cerebrovascular diseases (Basel, Switzerland) - 1 Jan 2009
Arnold Marie-Luise, Grond-Ginsbach Caspar, Kloss Manja, Di Mascio Maria-Teresa, Veltkamp Roland, Ringleb Peter, Lichy Christoph
Abstract excerpt
BACKGROUND: For many conditions causing transient ischemic attack or minor stroke, secondary prevention with early initiation of oral anticoagulation is indicated. The individual response to coumarins is known to vary widely and is not well predicted by clinical variables. Patients' discharge from hospital care is often delayed only because the therapeutic target range has not been reached yet. A feasible tool to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.